60% of the patients hospitalized in intensive care and sedated suffer from insufficient inferior eyelid occlusion. Thus, they are at risk for corneal damage (estimated risk 20% to 57%). The prevention of such corneal damage can be done using several techniques (artificial tears, eyelid occlusion dressing, aqueous gel). The efficacy of these techniques has never been compared in a rigorous study. Therefore it is not yet possible to determine an evidence-based strategy to prevent corneal damage in intensive care patients. This study aims at assessing the efficacy of primary prevention of corneal lesions in intensive care patients, in order to elaborate an evidence-based nursing protocol.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
49
1 drop of Dexpanthenol® 0.2% aqueous gel in the eye every 6 hours
Eyelid occlusion using pro-ophta® eyelid occlusion dressing, dressing to be verified every 6 hours and replaced daily
1 drop of Phylarm® artificial tears in the eye every 6 hours
Fondation ophtalmologique Adolphe de Rothschild
Paris, Île-de-France Region, France
Incidence rate of corneal lesions (grade > 0 in the Mercieca classification)
Time frame: participants will be followed for the duration of stay in intensive care unit, an expected average of 1 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.